Venus Remedies Limited has informed the Exchange regarding 'Venus Remedies Limited Secures Renewal of Prestigious DSIR in-house R&D Recognition'.
VENUSREM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Venus Remedies Limited has received a renewal of its DSIR (Department of Scientific and Industrial Research) recognition for its in-house Research & Development unit. DSIR recognition is a government acknowledgment granted to industrial R&D facilities that meet certain scientific and technical standards. This renewal indicates the company continues to meet the qualifying criteria for maintaining this status. The recognition typically supports eligibility for certain tax benefits, customs duty concessions on R&D imports, and enhances the company's credibility in innovation-driven segments of the pharmaceutical industry.
This is a routine regulatory renewal with no immediate material impact on revenue or earnings, though it helps the company retain tax incentives and strengthen its R&D credentials over the long term.